These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1649321)

  • 1. The topoisomerase I inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2Th cells.
    Priel E; Showalter SD; Roberts M; Oroszlan S; Blair DG
    J Virol; 1991 Aug; 65(8):4137-41. PubMed ID: 1649321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus (HIV-1) replication in vitro by noncytotoxic doses of camptothecin, a topoisomerase I inhibitor.
    Priel E; Showalter SD; Blair DG
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):65-72. PubMed ID: 1707642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.
    Lichtenstein DL; Rushlow KE; Cook RF; Raabe ML; Swardson CJ; Kociba GJ; Issel CJ; Montelaro RC
    J Virol; 1995 May; 69(5):2881-8. PubMed ID: 7707512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.
    Tang YD; Na L; Zhu CH; Shen N; Yang F; Fu XQ; Wang YH; Fu LH; Wang JY; Lin YZ; Wang XF; Wang X; Zhou JH; Li CY
    J Virol; 2014 Nov; 88(21):12296-310. PubMed ID: 25122784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The persistent infection of a canine thymus cell line by equine infectious anaemia virus and preliminary data on the production of viral antigens.
    Bouillant AM; Nielsen K; Ruckerbauer GM; Samagh BS; Hare WC
    J Virol Methods; 1986 Jul; 13(4):309-21. PubMed ID: 3018020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin treatment of equine infectious anaemia virus-infected horse macrophage cultures decreases production of infectious virus.
    Smith TA; Davis E; Carpenter S
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():747-55. PubMed ID: 9568970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine endothelial cells support productive infection of equine infectious anemia virus.
    Maury W; Oaks JL; Bradley S
    J Virol; 1998 Nov; 72(11):9291-7. PubMed ID: 9765477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.
    Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC
    J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine infectious anemia virus derived from a molecular clone persistently infects horses.
    Whetter L; Archambault D; Perry S; Gazit A; Coggins L; Yaniv A; Clabough D; Dahlberg J; Fuller F; Tronick S
    J Virol; 1990 Dec; 64(12):5750-6. PubMed ID: 2173767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
    Ji S; Na L; Ren H; Wang Y; Wang X
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
    Maury WJ; Carpenter S; Graves K; Chesebro B
    Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaemia virus.
    Perryman LE; O'Rourke KI; Mason PH; McGuire TC
    Immunology; 1990 Dec; 71(4):592-4. PubMed ID: 1703988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient suppression of equine immune responses by equine infectious anemia virus (EIAV).
    Newman MJ; Issel CJ; Truax RE; Powell MD; Horohov DW; Montelaro RC
    Virology; 1991 Sep; 184(1):55-66. PubMed ID: 1651604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and in vitro evaluation of an infectious clone of the equine infectious anemia virus vaccine strain EIAV(FDDV) with four reverse-mutated vaccine-specific sites in the S2 gene].
    Gao X; Jiang CG; Han XE; Zhao LP; Shen RX; Xiang WH; Zhou JH
    Bing Du Xue Bao; 2009 Jul; 25(4):309-15. PubMed ID: 19769166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection.
    Chen C; Li F; Montelaro RC
    J Virol; 2001 Oct; 75(20):9762-70. PubMed ID: 11559809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of gag precursor of equine infectious anaemia virus with monoclonal antibodies to the major viral core protein, p26.
    Hussain KA; Issel CJ; Rwambo PM; Arnizaut AB; Ball JM; Schnorr KL; Montelaro RC
    J Gen Virol; 1988 Jul; 69 ( Pt 7)():1719-24. PubMed ID: 2839604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of serum antibodies to equine infectious anemia virus reverse transcriptase.
    DeVico AL; Issel CJ; Le Grice SF; Payne SL; Montelaro RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):7-11. PubMed ID: 7678974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I.
    Zhang JL; Sharma PL; Li CJ; Dezube BJ; Pardee AB; Crumpacker CS
    Antimicrob Agents Chemother; 1997 May; 41(5):977-81. PubMed ID: 9145855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in host cell tropism associated with in vitro replication of equine infectious anemia virus.
    Carpenter S; Chesebro B
    J Virol; 1989 Jun; 63(6):2492-6. PubMed ID: 2470916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.